Related Experiment Video
Updated: Jun 19, 2026

05:25
Simultaneous Detection of Different Antibody Classes in a Multiplexed Serological Test
Published on: July 14, 2023
6th International Immunoglobulin Symposium: poster presentations
E Fernandez-Cruz1, S V Kaveri, H-H Peter
1Complutense University and University Hospital, Gregorio Marañón, Madrid, Spain. efernandezc.hgugm@salud.madrid.org
Clinical and Experimental Immunology
|November 4, 2009
Summary
This symposium showcased advancements in immunoglobulin (Ig) therapy, covering immunodeficiencies, autoimmunity, and basic science. Research highlighted improved treatments and a deeper understanding of Ig mechanisms for better patient care.
Area of Science:
- Immunology
- Clinical Research
- Biochemistry
Background:
- The 6th International Immunoglobulin Symposium convened to discuss diverse applications of immunoglobulin therapy.
- Presentations encompassed both fundamental scientific discoveries and clinical practice advancements.
Purpose of the Study:
- To present and discuss cutting-edge research in immunoglobulin therapy across multiple disciplines.
- To foster a deeper understanding of immunoglobulin mechanisms and their clinical implications.
Main Methods:
- Oral and poster presentations from a symposium covering immunodeficiencies, autoimmunity, and basic science.
- Selection of 12 abstracts for oral presentations from a larger pool of poster submissions.
Main Results:
- Immunodeficiency session: discussed rare class-switch recombination deficiencies, IVIg adverse events, IgG trough levels in XLA/CVID, and B cell reduction in SAD.
- Autoimmunity session: covered IVIg's impact on fetal alloimmune thrombocytopenia, multiple sclerosis, and experiences with subcutaneous Ig in multifocal motor neuropathy.
- Basic science session: explored DC-SIGN interactions, sialylated IgG enrichment, prion surveillance, and anti-measles antibody monitoring in Ig products.
Conclusions:
- Symposium presentations demonstrated the wide-ranging use of immunoglobulin therapy.
- Significant progress in basic and clinical research is enhancing the understanding of immunoglobulin action and improving patient outcomes.
Related Concept Videos
Humoral Immune Responses
Overview
Immunoglobulin-like Cell Adhesion Molecules
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...

